These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the TRUTH study). Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I; Am J Cardiol; 2012 May; 109(9):1247-53. PubMed ID: 22325089 [TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of serum n-3 to n-6 polyunsaturated fatty acid ratios on coronary atherosclerosis in patients treated with pitavastatin or pravastatin undergoing percutaneous coronary intervention. Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I Am J Cardiol; 2013 Jun; 111(11):1570-5. PubMed ID: 23497779 [TBL] [Abstract][Full Text] [Related]
6. Comparison of change in coronary atherosclerosis in patients with stable versus unstable angina pectoris receiving statin therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] study). Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I; Am J Cardiol; 2013 Apr; 111(7):923-9. PubMed ID: 23337838 [TBL] [Abstract][Full Text] [Related]
7. Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology. Kovarnik T; Chen Z; Mintz GS; Wahle A; Bayerova K; Kral A; Chval M; Kopriva K; Lopez J; Sonka M; Linhart A Cardiovasc Diabetol; 2017 Dec; 16(1):156. PubMed ID: 29212544 [TBL] [Abstract][Full Text] [Related]
9. Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease. Elshazly MB; Mani P; Nissen S; Brennan DM; Clark D; Martin S; Jones SR; Quispe R; Donnellan E; Nicholls SJ; Puri R Eur J Prev Cardiol; 2020 Jul; 27(10):1091-1100. PubMed ID: 31744333 [TBL] [Abstract][Full Text] [Related]
10. An omega-3 fatty acid plasma index ≥4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment. Alfaddagh A; Elajami TK; Saleh M; Mohebali D; Bistrian BR; Welty FK Atherosclerosis; 2019 Jun; 285():153-162. PubMed ID: 31055222 [TBL] [Abstract][Full Text] [Related]
11. Impact of statins on serial coronary calcification during atheroma progression and regression. Puri R; Nicholls SJ; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nissen SE J Am Coll Cardiol; 2015 Apr; 65(13):1273-1282. PubMed ID: 25835438 [TBL] [Abstract][Full Text] [Related]
12. Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial. Nakao K; Noguchi T; Asaumi Y; Morita Y; Kanaya T; Fujino M; Hosoda H; Yoneda S; Kawakami S; Nagai T; Nishihira K; Nakashima T; Kumasaka R; Arakawa T; Otsuka F; Nakanishi M; Kataoka Y; Tahara Y; Goto Y; Yamamoto H; Hamasaki T; Yasuda S Trials; 2018 Jan; 19(1):12. PubMed ID: 29310688 [TBL] [Abstract][Full Text] [Related]
13. Impact of diabetes mellitus on coronary atherosclerosis and plaque composition under statin therapy – subanalysis of the TRUTH study –. Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I; Circ J; 2012; 76(9):2188-96. PubMed ID: 22785608 [TBL] [Abstract][Full Text] [Related]
14. Impacts of conventional coronary risk factors, diabetes and hypertension, on coronary atherosclerosis during statin therapy: subanalysis of the TRUTH study. Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Hibi K; Terashima M; Michishita I; Coron Artery Dis; 2012 Jun; 23(4):239-44. PubMed ID: 22441135 [TBL] [Abstract][Full Text] [Related]
15. Impacts of estimated glomerular filtration rate on coronary atherosclerosis and plaque composition before and during statin therapy in patients with normal to mild renal dysfunction: subanalysis of the TRUTH study. Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Hibi K; Terashima M; Michishita I; Nephrology (Carlton); 2012 Sep; 17(7):628-35. PubMed ID: 22708952 [TBL] [Abstract][Full Text] [Related]
16. Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis. Nozue T; Yamamoto S; Tohyama S; Umezawa S; Kunishima T; Sato A; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Sozu T; Terashima M; Michishita I Am Heart J; 2012 Feb; 163(2):191-9.e1. PubMed ID: 22305836 [TBL] [Abstract][Full Text] [Related]
17. Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy. Puri R; Nissen SE; Shao M; Uno K; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ Am J Cardiol; 2014 Nov; 114(10):1465-72. PubMed ID: 25282317 [TBL] [Abstract][Full Text] [Related]
18. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM; JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939 [TBL] [Abstract][Full Text] [Related]